Literature DB >> 8227660

Forms of lactoferrin: their antibacterial effect on enterotoxigenic Escherichia coli.

D A Dionysius1, P A Grieve, J M Milne.   

Abstract

The antibacterial effects of various forms of lactoferrin on enterotoxigenic strains of Escherichia coli were tested in vitro using a microassay for bacterial growth. Native and apo-lactoferrin exhibited variable activity against 19 strains, whereas holo-lactoferrin had no effect. At a concentration of .2 mg/ml of apo-lactoferrin, strains could be distinguished as either sensitive or resistant to inhibition. Zinc-saturated lactoferrin was as inhibitory as apo-lactoferrin when sensitive and resistant strains were tested over the concentration range .04 to 1.0 mg/ml of lactoferrin. A bactericidal effect was observed for native, apo-, and Zn-saturated lactoferrin against some sensitive strains. The antibacterial activity of apo-lactoferrin depended on bacterial inoculum size and was not enhanced by the addition of lysozyme. Addition of holo-lactoferrin or cytochrome c diminished the antibacterial effect of apo-lactoferrin, whereas addition of BSA had no effect. Resistance to inhibition by lactoferrin was not related to the production of bacterial siderophores.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8227660     DOI: 10.3168/jds.S0022-0302(93)77594-3

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  11 in total

1.  Lactoferricin B inhibits the phosphorylation of the two-component system response regulators BasR and CreB.

Authors:  Yu-Hsuan Ho; Tzu-Cheng Sung; Chien-Sheng Chen
Journal:  Mol Cell Proteomics       Date:  2011-12-02       Impact factor: 5.911

2.  Porcine and Bovine Forms of Lactoferrin Inhibit Growth of Porcine Enterotoxigenic Escherichia coli and Degrade Its Virulence Factors.

Authors:  Bert Devriendt; Eric Cox; Matthias Dierick; Hans Van der Weken; Joanna Rybarczyk; Daisy Vanrompay
Journal:  Appl Environ Microbiol       Date:  2020-11-24       Impact factor: 4.792

3.  The Pepsin Hydrolysate of Bovine Lactoferrin Causes a Collapse of the Membrane Potential in Escherichia coli O157:H7.

Authors:  Christopher Murdock; Michael L Chikindas; Karl R Matthews
Journal:  Probiotics Antimicrob Proteins       Date:  2010-06       Impact factor: 4.609

4.  Transgenic cows that produce recombinant human lactoferrin in milk are not protected from experimental Escherichia coli intramammary infection.

Authors:  P Hyvönen; L Suojala; T Orro; J Haaranen; O Simola; C Røntved; S Pyörälä
Journal:  Infect Immun       Date:  2006-09-05       Impact factor: 3.441

5.  Antibacterial activity in bovine lactoferrin-derived peptides.

Authors:  K S Hoek; J M Milne; P A Grieve; D A Dionysius; R Smith
Journal:  Antimicrob Agents Chemother       Date:  1997-01       Impact factor: 5.191

6.  Distribution of lactoferrin and 60/65 kDa heat shock protein in normal and inflamed human intestine and liver.

Authors:  E Peen; S Eneström; T Skogh
Journal:  Gut       Date:  1996-01       Impact factor: 23.059

Review 7.  The Immunology of Mammary Gland of Dairy Ruminants between Healthy and Inflammatory Conditions.

Authors:  Mohamed Ezzat Alnakip; Marcos Quintela-Baluja; Karola Böhme; Inmaculada Fernández-No; Sonia Caamaño-Antelo; Pillar Calo-Mata; Jorge Barros-Velázquez
Journal:  J Vet Med       Date:  2014-11-10

8.  Growth comparison of several Escherichia coli strains exposed to various concentrations of lactoferrin using linear spline regression.

Authors:  Camilla Sekse; Jon Bohlin; Eystein Skjerve; Gerd E Vegarud
Journal:  Microb Inform Exp       Date:  2012-04-16

9.  Bovine lactoferrin decreases cholera-toxin-induced intestinal fluid accumulation in mice by ganglioside interaction.

Authors:  Fulton P Rivera; Anicia M Medina; Sandra Bezada; Roberto Valencia; María Bernal; Rina Meza; Ryan C Maves; Theresa J Ochoa
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240

10.  Antibacterial effect of bovine lactoferrin against udder pathogens.

Authors:  T Kutila; S Pyörälä; H Saloniemi; L Kaartinen
Journal:  Acta Vet Scand       Date:  2003       Impact factor: 1.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.